In this edition of By the Numbers, we discuss medication shifts in people with autism, outpatient facilities providing autism care and pandemic-induced behavioral changes in autistic children.

Reports of flaws in imaging research are signs of a maturing field, experts say, not a devastating blow to its results.

Over the course of a career spanning more than three decades, Huda Zoghbi has won almost every major biology and neuroscience research award that exists. More than 20 years since she discovered the gene behind Rett syndrome, she remains laser focused on unlocking the condition’s secrets and finding effective treatments.

The U.S. Food and Drug Administration has given the okay to an app designed to help clinicians diagnose autism in children, but some researchers have concerns about its use.

Methods that selectively increase levels of the Rett protein make for safer and more effective treatment strategies, some researchers say.

Zemi Yenus was the mother of a child with autism, founder of Ethiopia’s first school for autistic children and a tireless advocate for autism awareness and research in Africa.

After a year of juggling research, childcare and COVID-19 anxiety, some early-career academics are rethinking their place in autism science.

After a study revised a popular measure for alexithymia, it was pulled for copyright infringement because the authors did not pay a $40 fee or obtain permission to use the measure.

As cannabis prohibition slowly lifts in the United States, scientists and families in the autism community are increasingly turning to the drug and its constituent compounds to ease autism-related difficulties, including seizures and irritability.

The high levels of serotonin seen in the blood of some autistic people have confounded scientists for more than half a century. Despite so little progress, some researchers refuse to give up.